Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LUIS CASAUBON

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1447225495
CMS profile
20091
Location
AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$436.66

18 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $436.66 18

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Medtronic, Inc. $210.16 12
Novo Nordisk Inc $115.71 2
Amgen Inc. $63.99 2
Amphastar Pharmaceuticals, Inc. $24.67 1
Abbott Laboratories $22.13 1

Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LUIS CASAUBON

NPI 1447225495 · CMS profile ID 20091

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1447225495?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447225495?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447225495?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1447225495?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

18 matching records · $436.66 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 18 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–18 of 18.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Medtronic, Inc. $0.6412/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119320573 CMS
Medtronic, Inc. $1.3812/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119320571 CMS
Amgen Inc. $18.4711/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111543905 CMS
Amphastar Pharmaceuticals, Inc. $24.6711/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149953147 CMS
Medtronic, Inc. $1.9810/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119320569 CMS
Medtronic, Inc. $1.9509/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119320565 CMS
Medtronic, Inc. $0.1609/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119320567 CMS
Medtronic, Inc. $1.9309/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119320563 CMS
Amgen Inc. $45.5206/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117521919 CMS
Medtronic, Inc. $7.9906/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119320561 CMS
Novo Nordisk Inc $27.3806/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097422463 CMS
Medtronic, Inc. $166.6006/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119320559 CMS
Medtronic, Inc. $1.8806/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119320557 CMS
Abbott Laboratories $22.1305/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125068645 CMS
Medtronic, Inc. $0.7105/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119320553 CMS
Medtronic, Inc. $24.3105/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119320555 CMS
Medtronic, Inc. $0.6304/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119320551 CMS
Novo Nordisk Inc $88.3301/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097829288 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $17.84 1
PY2021 $120.24 6
PY2022 $75.60 4
PY2023 $271.82 14
PY2024 $436.66 18
PY2025 $588.22 24

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $244,802.34 43
PY2024 Principal investigator $270,911.58 97
PY2023 Principal investigator $213,259.54 161
PY2022 Principal investigator $530,223.08 203
PY2021 Principal investigator $866,406.89 1,203
PY2020 Recipient $7,732.50 3
PY2020 Principal investigator $630,563.16 449
PY2019 Principal investigator $775,897.49 183

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

452 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $41.00 12/30/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 822176299
Principal investigator 1 Novo Nordisk AS $5.00 12/29/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 822166301
Principal investigator 1 Novo Nordisk AS $41.00 12/29/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 822166303
Principal investigator 1 Novo Nordisk AS $5.00 12/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 822166293
Principal investigator 1 Novo Nordisk AS $41.00 12/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 822166295
Principal investigator 1 Novo Nordisk AS $41.00 12/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 822176297
Principal investigator 1 Novo Nordisk AS $3,810.38 12/22/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422641
Principal investigator 1 Novo Nordisk AS $352.60 12/22/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422643
Principal investigator 1 Novo Nordisk AS $260.00 12/22/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422645
Principal investigator 1 Novo Nordisk AS $3,000.00 12/22/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742422647
Principal investigator 1 Novo Nordisk AS $1,000.00 12/22/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742422649
Principal investigator 1 Novo Nordisk AS $310.73 12/22/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422657
Principal investigator 1 Novo Nordisk AS $100.00 12/22/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422659
Principal investigator 1 Novo Nordisk AS $5.00 12/21/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 822166297
Principal investigator 1 Novo Nordisk AS $41.00 12/21/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 822166299
Principal investigator 1 Eli Lilly and Company $23,775.00 12/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN STUDY PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS PREVIOUSLY TREATED WITH MULTIPLE DAILY INJECTION THERAPY No dispute reported 06/30/2026 728749831
Principal investigator 1 Novo Nordisk AS $41.00 12/14/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 822176291
Principal investigator 1 Novo Nordisk AS $32.00 12/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 822166291
Principal investigator 1 Abbott Laboratories $47,797.62 12/09/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748233
Principal investigator 1 Novo Nordisk AS $41.00 12/09/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 822176293
Principal investigator 1 Novo Nordisk AS $41.00 12/09/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 822176295
Principal investigator 1 Novo Nordisk AS $5.00 12/07/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 822166283
Principal investigator 1 Novo Nordisk AS $41.00 12/07/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 822166285
Principal investigator 1 Novo Nordisk AS $4.00 12/07/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 822167771
Principal investigator 1 Novo Nordisk AS $41.00 12/04/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 822176289
Principal investigator 1 Medtronic MiniMed, Inc. $955.10 12/02/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041581
Principal investigator 1 Abbott Laboratories $15,932.50 12/01/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748231
Principal investigator 1 Novo Nordisk AS $5.00 12/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 822166287
Principal investigator 1 Novo Nordisk AS $41.00 12/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 822166289
Principal investigator 1 Abbott Laboratories $525.00 11/30/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748229
Principal investigator 1 Novo Nordisk AS $41.06 11/30/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422559
Principal investigator 1 Novo Nordisk AS $4,820.65 11/30/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422639
Principal investigator 1 Novo Nordisk AS $1,417.50 11/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422651
Principal investigator 1 Novo Nordisk AS $356.78 11/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422653
Principal investigator 1 Novo Nordisk AS $100.00 11/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422655
Principal investigator 1 Novo Nordisk AS $297.63 11/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422661
Principal investigator 1 Novo Nordisk AS $200.00 11/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422663
Principal investigator 1 Novo Nordisk AS $41.06 11/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422561
Principal investigator 1 Novo Nordisk AS $0.30 11/20/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421651
Principal investigator 1 Novo Nordisk AS $5.72 11/20/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421653
Principal investigator 1 Novo Nordisk AS $325.80 11/20/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421655
Principal investigator 1 Novo Nordisk AS $891.00 11/20/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421657
Principal investigator 1 Novo Nordisk AS $439.20 11/20/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421659
Principal investigator 1 Eli Lilly and Company $3,289.46 11/19/2020 Non-covered Recipient Entity
REIFY HEALTH INC
A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN STUDY PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS PREVIOUSLY TREATED WITH MULTIPLE DAILY INJECTION THERAPY No dispute reported 06/30/2026 728747277
Principal investigator 1 Medtronic MiniMed, Inc. $1,282.20 11/18/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041559
Principal investigator 1 Medtronic MiniMed, Inc. $240.00 11/18/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041571
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421661
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421663
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421665
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421667
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421669
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421671
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421673
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421675
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421677
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421679
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421681
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421683
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421685
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421687
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421689
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421691
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421693
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421695
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421697
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421699
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421701
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421703
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421705
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421707
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421709
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421711
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421713
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421715
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421717
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421719
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421721
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421723
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421725
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421727
Principal investigator 1 Novo Nordisk AS $1.95 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421729
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421731
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421733
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421735
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421737
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421739
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421741
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421743
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421745
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421747
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421749
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421751
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421753
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421755
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421757
Principal investigator 1 Novo Nordisk AS $5.30 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421759
Principal investigator 1 Novo Nordisk AS $3.02 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421761
Principal investigator 1 Novo Nordisk AS $22.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421763
Principal investigator 1 Novo Nordisk AS $8.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421765
Principal investigator 1 Novo Nordisk AS $72.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421767
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421769
Principal investigator 1 Novo Nordisk AS $39.90 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421771
Principal investigator 1 Novo Nordisk AS $6.50 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421773
Principal investigator 1 Novo Nordisk AS $9.74 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421775
Principal investigator 1 Novo Nordisk AS $40.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421777
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421779
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421781
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421783
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421785
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421787
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421789
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421791
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421793
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421795
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421797
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421799
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421801
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421803
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421805
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421807
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421809
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742421811
Principal investigator 1 Novo Nordisk AS $5.20 11/16/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422567
Principal investigator 1 Novo Nordisk AS $41.06 11/16/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422569
Principal investigator 1 Novo Nordisk AS $41.06 11/13/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422565
Principal investigator 1 Medtronic MiniMed, Inc. $70.95 11/10/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041543
Principal investigator 1 Novo Nordisk AS $4,627.15 11/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 742422671
Principal investigator 1 Novo Nordisk AS $562.00 11/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742422673
Principal investigator 1 Novo Nordisk AS $1,182.00 11/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 742422675
Principal investigator 1 Abbott Laboratories $4,912.50 11/02/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748235
Principal investigator 1 Novo Nordisk AS $1,697.07 10/29/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422613
Principal investigator 1 Novo Nordisk AS $1,063.12 10/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422583
Principal investigator 1 Novo Nordisk AS $400.13 10/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422585
Principal investigator 1 Novo Nordisk AS $200.00 10/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422587
Principal investigator 1 Novo Nordisk AS $466.62 10/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422601
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422509
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422511
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422513
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422515
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422517
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422519
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422521
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422523
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422525
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422527
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422529
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422537
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422539
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422541
Principal investigator 1 Novo Nordisk AS $432.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422543
Principal investigator 1 Abbott Laboratories $315.00 10/09/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748225
Principal investigator 1 Novo Nordisk AS $41.06 10/09/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422507
Principal investigator 1 Abbott Laboratories $10,375.00 10/06/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748227
Principal investigator 1 Novo Nordisk AS $41.06 09/30/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422627
Principal investigator 1 Novo Nordisk AS $254.44 09/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422581
Principal investigator 1 Novo Nordisk AS $41.06 09/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422629
Principal investigator 1 Novo Nordisk AS $41.06 09/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422631
Principal investigator 1 Medtronic MiniMed, Inc. $472.75 09/22/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041519
Principal investigator 1 Novo Nordisk AS $774.00 09/22/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422597
Principal investigator 1 Novo Nordisk AS $373.04 09/22/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422599
Principal investigator 1 Novo Nordisk AS $1,000.00 09/22/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 742422611
Principal investigator 1 Abbott Laboratories $15,237.50 09/14/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748223
Principal investigator 1 Novo Nordisk AS $41.06 09/14/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422633
Principal investigator 1 Novo Nordisk AS $41.46 09/10/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422637
Principal investigator 1 Medtronic MiniMed, Inc. $640.00 09/09/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041624
Principal investigator 1 Novo Nordisk AS $0.32 09/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422635
Principal investigator 1 Novo Nordisk AS $5,237.45 08/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422589
Principal investigator 1 Novo Nordisk AS $260.00 08/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422591
Principal investigator 1 Novo Nordisk AS $73.44 08/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422593
Principal investigator 1 Novo Nordisk AS $100.00 08/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422595
Principal investigator 1 Novo Nordisk AS $23.46 08/26/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422459
Principal investigator 1 Novo Nordisk AS $4,097.25 08/25/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422571
Principal investigator 1 Novo Nordisk AS $3,931.20 08/25/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422573
Principal investigator 1 Novo Nordisk AS $141.18 08/25/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422575
Principal investigator 1 Novo Nordisk AS $300.00 08/25/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422577
Principal investigator 1 Novo Nordisk AS $100.00 08/25/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422579
Principal investigator 1 Novo Nordisk AS $23.46 08/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422457
Principal investigator 1 Novo Nordisk AS $23.46 08/20/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422505
Principal investigator 1 Medtronic MiniMed, Inc. $1,866.00 08/19/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041615
Principal investigator 1 Novo Nordisk AS $19.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422461
Principal investigator 1 Novo Nordisk AS $19.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422463
Principal investigator 1 Novo Nordisk AS $19.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422465
Principal investigator 1 Novo Nordisk AS $19.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422467
Principal investigator 1 Novo Nordisk AS $19.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422469
Principal investigator 1 Novo Nordisk AS $19.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422471
Principal investigator 1 Novo Nordisk AS $19.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422473
Principal investigator 1 Novo Nordisk AS $19.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422475
Principal investigator 1 Novo Nordisk AS $19.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422477
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422479
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422481
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422483
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422485
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422487
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422489
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422491
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422493
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422495
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422497
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422499
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422501
Principal investigator 1 Novo Nordisk AS $450.00 08/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422503
Principal investigator 1 Medtronic MiniMed, Inc. $3,151.70 08/05/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041606
Recipient Eli Lilly and Company $142.50 07/31/2020 Covered Recipient Physician A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 728720597
Principal investigator 1 Novo Nordisk AS $2,362.50 07/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422283
Principal investigator 1 Novo Nordisk AS $2,948.40 07/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422285
Principal investigator 1 Novo Nordisk AS $200.00 07/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422287
Principal investigator 1 Novo Nordisk AS $1,687.50 07/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422291
Principal investigator 1 Novo Nordisk AS $39.96 07/13/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422557
Principal investigator 1 Novo Nordisk AS $9.99 07/07/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422553
Principal investigator 1 Novo Nordisk AS $45.96 07/07/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422555
Principal investigator 1 Novo Nordisk AS $9.99 07/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422549
Principal investigator 1 Novo Nordisk AS $45.96 07/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422551
Principal investigator 1 Abbott Laboratories $2,718.75 06/30/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748221
Principal investigator 1 Novo Nordisk AS $9.99 06/30/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422447
Principal investigator 1 Novo Nordisk AS $45.96 06/30/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422449
Principal investigator 1 Novo Nordisk AS $23.06 06/29/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422455
Principal investigator 1 Novo Nordisk AS $904.50 06/25/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422289
Principal investigator 1 Novo Nordisk AS $111.30 06/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422281
Principal investigator 1 Medtronic MiniMed, Inc. $2,982.00 06/16/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041593
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422303
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422305
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422307
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422309
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422311
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422313
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422315
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422317
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422319
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422321
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422323
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422325
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422327
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422329
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422331
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422333
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422335
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422337
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422339
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422341
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422343
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422345
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422347
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422349
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422351
Principal investigator 1 Novo Nordisk AS $15.30 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422353
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422355
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422357
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422359
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422361
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422363
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422365
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422367
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422369
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422371
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422373
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422375
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422377
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422379
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422381
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422383
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422385
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422387
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422389
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422391
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422393
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422395
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422397
Principal investigator 1 Novo Nordisk AS $11.38 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422399
Principal investigator 1 Novo Nordisk AS $9.98 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422401
Principal investigator 1 Novo Nordisk AS $9.98 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422403
Principal investigator 1 Novo Nordisk AS $9.98 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422405
Principal investigator 1 Novo Nordisk AS $9.98 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422407
Principal investigator 1 Novo Nordisk AS $9.98 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422409
Principal investigator 1 Novo Nordisk AS $9.98 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422411
Principal investigator 1 Novo Nordisk AS $9.98 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422413
Principal investigator 1 Novo Nordisk AS $9.98 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422415
Principal investigator 1 Novo Nordisk AS $9.98 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422417
Principal investigator 1 Novo Nordisk AS $9.98 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422419
Principal investigator 1 Novo Nordisk AS $9.98 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422421
Principal investigator 1 Novo Nordisk AS $360.00 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422423
Principal investigator 1 Novo Nordisk AS $360.00 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422425
Principal investigator 1 Novo Nordisk AS $360.00 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422427
Principal investigator 1 Novo Nordisk AS $360.00 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422429
Principal investigator 1 Novo Nordisk AS $360.00 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422431
Principal investigator 1 Novo Nordisk AS $360.00 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422433
Principal investigator 1 Novo Nordisk AS $360.00 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422435
Principal investigator 1 Novo Nordisk AS $360.00 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422437
Principal investigator 1 Novo Nordisk AS $360.00 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422439
Principal investigator 1 Novo Nordisk AS $360.00 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422441
Principal investigator 1 Novo Nordisk AS $360.00 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422443
Principal investigator 1 Novo Nordisk AS $360.00 06/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422445
Principal investigator 1 Abbott Laboratories $4,856.25 06/01/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748219
Principal investigator 1 Novo Nordisk AS $1,010.53 05/29/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421879
Principal investigator 1 Novo Nordisk AS $30.57 05/29/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421881
Principal investigator 1 Novo Nordisk AS $150.00 05/29/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421883
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422203
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422205
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422207
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422209
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422211
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422213
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422215
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422217
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422219
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422221
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422223
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422225
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422227
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422229
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422231
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422233
Principal investigator 1 Novo Nordisk AS $32.50 05/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422235
Principal investigator 1 Novo Nordisk AS $1,871.45 05/26/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742421859
Principal investigator 1 Novo Nordisk AS $1,782.00 05/26/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742421861
Principal investigator 1 Novo Nordisk AS $224.11 05/26/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742421863
Principal investigator 1 Novo Nordisk AS $250.00 05/26/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742421865
Principal investigator 1 Medtronic MiniMed, Inc. $2,190.10 05/18/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041531
Principal investigator 1 Novo Nordisk AS $1.99 05/07/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742422237
Recipient Eli Lilly and Company $3,795.00 05/04/2020 Covered Recipient Physician A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN STUDY PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS PREVIOUSLY TREATED WITH MULTIPLE DAILY INJECTION THERAPY No dispute reported 06/30/2026 728722745
Principal investigator 1 Abbott Laboratories $968.75 05/01/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748217
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422065
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422067
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422069
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422071
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422073
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422075
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422077
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422079
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422081
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422083
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422085
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422087
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422089
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422091
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422093
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422095
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422097
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422099
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422101
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422103
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422105
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422107
Principal investigator 1 Novo Nordisk AS $11.38 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422109
Principal investigator 1 Novo Nordisk AS $9.98 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422111
Principal investigator 1 Novo Nordisk AS $9.98 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422113
Principal investigator 1 Novo Nordisk AS $9.98 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422115
Principal investigator 1 Novo Nordisk AS $9.98 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422117
Principal investigator 1 Novo Nordisk AS $9.98 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422119
Principal investigator 1 Novo Nordisk AS $9.98 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422121
Principal investigator 1 Novo Nordisk AS $9.98 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422123
Principal investigator 1 Novo Nordisk AS $9.98 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422125
Principal investigator 1 Novo Nordisk AS $9.98 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422127
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422129
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422131
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422133
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422135
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422137
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422139
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422141
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422143
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422145
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422147
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422149
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422151
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422153
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422155
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422157
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422159
Principal investigator 1 Novo Nordisk AS $6.50 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422161
Principal investigator 1 Novo Nordisk AS $360.00 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422163
Principal investigator 1 Novo Nordisk AS $360.00 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422165
Principal investigator 1 Novo Nordisk AS $360.00 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422167
Principal investigator 1 Novo Nordisk AS $360.00 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422169
Principal investigator 1 Novo Nordisk AS $360.00 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422171
Principal investigator 1 Novo Nordisk AS $360.00 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422173
Principal investigator 1 Novo Nordisk AS $360.00 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422175
Principal investigator 1 Novo Nordisk AS $360.00 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422177
Principal investigator 1 Novo Nordisk AS $360.00 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422179
Principal investigator 1 Novo Nordisk AS $360.00 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422181
Principal investigator 1 Novo Nordisk AS $360.00 05/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422183
Principal investigator 1 Novo Nordisk AS $2,495.27 04/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742421855
Principal investigator 1 Novo Nordisk AS $2,376.00 04/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742421857
Principal investigator 1 Novo Nordisk AS $623.53 04/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421877
Recipient Eli Lilly and Company $3,795.00 04/20/2020 Covered Recipient Physician A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 728720591
Principal investigator 1 Medtronic MiniMed, Inc. $666.50 04/13/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041507
Principal investigator 1 Abbott Laboratories $2,737.50 04/03/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748213
Principal investigator 1 Novo Nordisk AS $774.00 03/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421873
Principal investigator 1 Novo Nordisk AS $130.00 03/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421875
Principal investigator 1 Medtronic MiniMed, Inc. $7,775.40 03/18/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041493
Principal investigator 1 Eli Lilly and Company $4,195.07 03/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 728749819
Principal investigator 1 AstraZeneca Pharmaceuticals LP $5,145.00 03/03/2020 Non-covered Recipient Entity
Texas Diabetes And Endocrinology, Pa
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacodynamic Effects of MEDI0382 in Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH) No dispute reported 06/30/2026 736737789
Principal investigator 1 Novo Nordisk AS $3,150.00 02/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742421837
Principal investigator 1 Novo Nordisk AS $3,931.20 02/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742421839
Principal investigator 1 Eli Lilly and Company $9,959.17 02/26/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN STUDY PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS PREVIOUSLY TREATED WITH MULTIPLE DAILY INJECTION THERAPY No dispute reported 06/30/2026 728749823
Principal investigator 1 Novo Nordisk AS $2,065.50 02/25/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421871
Principal investigator 1 Novo Nordisk AS $893.82 02/25/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 742421889
Principal investigator 1 Medtronic MiniMed, Inc. $3,182.90 02/17/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041482
Principal investigator 1 Novo Nordisk AS $31.20 02/07/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421895
Principal investigator 1 Novo Nordisk AS $37.00 02/07/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421897
Principal investigator 1 Novo Nordisk AS $15.25 02/07/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421899
Principal investigator 1 Novo Nordisk AS $80.00 02/07/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421901
Principal investigator 1 Novo Nordisk AS $49.75 02/07/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421903
Principal investigator 1 Novo Nordisk AS $31.60 02/07/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421905
Principal investigator 1 Novo Nordisk AS $2,362.50 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742421833
Principal investigator 1 Novo Nordisk AS $2,948.40 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742421835
Principal investigator 1 Novo Nordisk AS $63.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421867
Principal investigator 1 Novo Nordisk AS $3,327.19 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421869
Principal investigator 1 Novo Nordisk AS $1,233.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 742421885
Principal investigator 1 Novo Nordisk AS $540.00 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421959
Principal investigator 1 Novo Nordisk AS $540.00 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421961
Principal investigator 1 Novo Nordisk AS $540.00 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421963
Principal investigator 1 Novo Nordisk AS $540.00 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421965
Principal investigator 1 Novo Nordisk AS $540.00 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421967
Principal investigator 1 Novo Nordisk AS $540.00 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421969
Principal investigator 1 Novo Nordisk AS $540.00 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421971
Principal investigator 1 Novo Nordisk AS $540.00 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421973
Principal investigator 1 Novo Nordisk AS $540.00 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421975
Principal investigator 1 Novo Nordisk AS $540.00 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421977
Principal investigator 1 Novo Nordisk AS $21.20 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421979
Principal investigator 1 Novo Nordisk AS $21.20 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421981
Principal investigator 1 Novo Nordisk AS $21.20 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421983
Principal investigator 1 Novo Nordisk AS $21.20 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421985
Principal investigator 1 Novo Nordisk AS $21.20 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421987
Principal investigator 1 Novo Nordisk AS $21.20 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421989
Principal investigator 1 Novo Nordisk AS $21.20 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421991
Principal investigator 1 Novo Nordisk AS $21.20 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421993
Principal investigator 1 Novo Nordisk AS $21.20 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421995
Principal investigator 1 Novo Nordisk AS $21.20 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421997
Principal investigator 1 Novo Nordisk AS $21.20 01/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421999
Principal investigator 1 Novo Nordisk AS $540.00 01/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422045
Principal investigator 1 Novo Nordisk AS $540.00 01/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422047
Principal investigator 1 Novo Nordisk AS $540.00 01/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422049
Principal investigator 1 Novo Nordisk AS $540.00 01/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422051
Principal investigator 1 Novo Nordisk AS $540.00 01/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422053
Principal investigator 1 Novo Nordisk AS $540.00 01/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422055
Principal investigator 1 Novo Nordisk AS $540.00 01/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422057
Principal investigator 1 Novo Nordisk AS $540.00 01/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422059
Principal investigator 1 Novo Nordisk AS $540.00 01/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422061
Principal investigator 1 Novo Nordisk AS $540.00 01/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742422063
Principal investigator 1 Abbott Laboratories $75,000.00 01/22/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748215
Principal investigator 1 Abbott Laboratories $4,000.00 01/17/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 751748211
Principal investigator 1 Medtronic MiniMed, Inc. $3,139.15 01/14/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041469
Principal investigator 1 Medtronic MiniMed, Inc. $243,433.72 01/14/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728053157
Principal investigator 1 Novo Nordisk AS $7.40 01/10/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421947
Principal investigator 1 Novo Nordisk AS $3.05 01/10/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421949
Principal investigator 1 Novo Nordisk AS $9.95 01/10/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421951
Principal investigator 1 Novo Nordisk AS $9.95 01/09/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421955
Principal investigator 1 Novo Nordisk AS $9.95 01/09/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421957
Principal investigator 1 Medtronic MiniMed, Inc. $6,655.65 01/06/2020 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 728041453
Principal investigator 1 Novo Nordisk AS $46.12 01/06/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 742421953
Principal investigator 1 Novo Nordisk AS $7.40 01/02/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421943
Principal investigator 1 Novo Nordisk AS $3.05 01/02/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 742421945